All Brands Owned by The Cooper Companies, Inc.

What does CooperCompanies own?
CooperCompanies owns two business segments. CooperVision manufactures and markets contact lenses under brands including Biofinity, MyDay, Clariti, Avaira, and MiSight 1 day, along with private label lenses. CooperSurgical provides fertility and women's health products including IVF media, culture oil, catheters, and the PARAGARD intrauterine device. The company sells products in over 130 countries.

Is CooperCompanies publicly traded?
Yes. The Cooper Companies, Inc. trades on the Nasdaq Global Select Market under the ticker symbol COO. The company files annual reports (Form 10-K) and quarterly reports (Form 10-Q) with the U.S. Securities and Exchange Commission. Its fiscal year ends on October 31. CooperCompanies is a component of the S&P 500 index.

Who founded CooperCompanies?
CooperCompanies was founded in 1958 as Cooper Laboratories by Parker Montgomery, a Harvard-educated attorney who built the company through acquisitions in the healthcare equipment and services industry. The company was originally called Martin H. Smith Co. before changing its name to Cooper Laboratories, Inc. in 1967. The current corporate structure was established in 1987.

What is CooperCompanies' revenue?
CooperCompanies reported fiscal 2025 revenue of $4,092.4 million, up 5 percent from $3,895.4 million in fiscal 2024. The fiscal year ended October 31, 2025. CooperVision contributed $2,743.8 million, and CooperSurgical contributed $1,348.6 million. The company provided fiscal 2026 revenue guidance of $4,299 to $4,338 million.

Where is CooperCompanies headquartered?
CooperCompanies is headquartered in San Ramon, California. The CooperVision division maintains its operational headquarters in Pleasanton, California. CooperVision also has offices in Victor and Fairport, New York. Manufacturing facilities are located in Puerto Rico, New York, Costa Rica, Hungary, and the United Kingdom.

What is MiSight 1 day?
MiSight 1 day is a daily disposable soft contact lens approved by the FDA in November 2019 as the first and only product to slow the progression of myopia in children aged 8 to 12 at the initiation of treatment. It has also received approval in China and Japan. MiSight is a key growth product for CooperVision and is manufactured at the Ponce, Puerto Rico facility.

Has CooperVision had any recalls?
Yes. CooperVision issued several voluntary Class II recalls in 2024 and 2025 affecting MyDay Toric, Biofinity XR Toric, Biofinity Toric Multifocal, and Sofmed Breathables lenses. Issues included incorrect cylinder power, leaking blister seals, and invalid sterilization cycles in specific lots. All were classified as Class II by the FDA, and no permanent injuries were reported.